Hydroxyzine is NOT contraindicated in POTS
Hydroxyzine is not specifically contraindicated in patients with POTS, but it should be used with significant caution due to its QT-prolonging effects and potential to worsen orthostatic symptoms through sedation and CNS depression.
Key Concerns with Hydroxyzine in POTS
QT Prolongation Risk
The primary concern is that hydroxyzine is contraindicated in patients with prolonged QT interval 1. The FDA label explicitly warns that hydroxyzine can cause QT prolongation and Torsade de Pointes, particularly in patients with:
- Pre-existing heart disease
- Electrolyte imbalances
- Concomitant use of other QT-prolonging medications 1
While POTS itself does not inherently cause QT prolongation, many patients with POTS are treated with medications that can affect the QT interval. The 2020 Canadian Cardiovascular Society guidelines list common POTS medications including beta-blockers, ivabradine, and various other agents 2. If a POTS patient is on any QT-prolonging medications (such as certain antiarrhythmics, antipsychotics, or antibiotics), adding hydroxyzine creates additional risk 1.
Sedation and Orthostatic Symptoms
Hydroxyzine causes significant CNS depression and drowsiness 1. This is problematic in POTS because:
- Sedation may worsen the "brain fog" and cognitive impairment already common in POTS patients
- CNS depressants can potentially impair compensatory mechanisms needed for orthostatic tolerance
- The sedating effects may interfere with the exercise training programs that are strongly recommended for all POTS patients 2
Clinical Decision Algorithm
Before prescribing hydroxyzine to a POTS patient:
Obtain a baseline ECG to rule out prolonged QT interval (if QTc >450ms in men or >470ms in women, hydroxyzine is contraindicated) 1
Review all current medications for QT-prolonging agents - if present, avoid hydroxyzine or use extreme caution with ECG monitoring 1
Check electrolytes (potassium, magnesium, calcium) - correct any abnormalities before considering hydroxyzine 1
Consider the indication carefully - if hydroxyzine is being used for anxiety or sleep, alternative agents without QT effects may be preferable in POTS patients
If hydroxyzine must be used:
- Start at the lowest effective dose
- Monitor for worsening orthostatic symptoms
- Warn patients about increased drowsiness and avoid combining with other CNS depressants 1
- Consider repeat ECG monitoring, especially if other risk factors are present
Important Caveats
The major POTS treatment guidelines 2 do not specifically address antihistamines like hydroxyzine, as they focus on medications that improve central blood volume, enhance vasoconstriction, or reduce sinus tachycardia. Hydroxyzine does none of these and may theoretically worsen symptoms through sedation.
The absolute contraindication is prolonged QT interval 1, not POTS itself. However, the overlap of risk factors (young women, potential electrolyte abnormalities from high salt intake and fludrocortisone use, polypharmacy) means POTS patients warrant extra scrutiny before hydroxyzine prescription.